Hypofractionated Radiotherapy as a Standalone Treatment Modality for Locally Advanced Type B2 Thymoma in an Octogenarian Patient: 45 Gy in 15 Fractions
- PMID: 38304685
- PMCID: PMC10833057
- DOI: 10.7759/cureus.51528
Hypofractionated Radiotherapy as a Standalone Treatment Modality for Locally Advanced Type B2 Thymoma in an Octogenarian Patient: 45 Gy in 15 Fractions
Abstract
Thymic epithelial tumors (TETs), particularly type B2 thymomas, are rare neoplasms primarily found in the anterior mediastinum. The current therapeutic approach includes surgery, chemotherapy, and radiotherapy, but there is limited research on radiotherapy as a standalone treatment. This case report aims to elucidate the clinical outcomes of hypofractionated radiotherapy as a standalone treatment for locally advanced type B2 thymoma, offering insights into its potential efficacy and role in clinical practice.
Keywords: definitive treatment; hypofractionation; octogenarian; radiotherapy; thymoma.
Copyright © 2024, Katano et al.
Conflict of interest statement
Masanari Minamitani, and Shingo Ohira are affiliated with the Department of Comprehensive Radiation Oncology, which is an endowed department funded by an unrestricted grant from Elekta K.K. and Chiyoda Technol Corporation. However, it is important to note that no funding was received from them specifically to conduct this study.
Figures



References
-
- Molecular landscape of thymic epithelial tumors. Prays J, Ortiz-Villalón C. Semin Diagn Pathol. 2022;39:131–136. - PubMed
-
- Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Ann Oncol. 2015;26 Suppl 5:0–55. - PubMed
Publication types
LinkOut - more resources
Full Text Sources